| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |